Megan (Reddington) Berg
Director, Trial Initiation Oncology @ Merck
About Megan (Reddington) Berg
Megan (Reddington) Berg serves as the Director of Trial Initiation in Oncology at Merck, a position she has held since 2022. With extensive experience in trial initiation processes and a background in various roles within the pharmaceutical industry, she has developed strong project management and stakeholder relationship skills.